GAVI Alliance Board

CEO report to the Board.

This report summarises the Executive Committee’s activities and recommendations since the Geneva board meeting on 16-17 June 2010.

Annex 5 - SG2 Time Limited Task Team Chair's Summary.

Annex 2 Part II - Strategic Goals and Cross Cutting-Issues.

This document updates the GAVI Alliance Board on the implementation of GAVI's resource mobilisation strategy.

This document has been prepared by the Secretariat of the Decade of Vaccines (DoV) Collaboration for the information of the GAVI Alliance Board.

On Monday 9 August 2010 the GAVI Alliance Board Chair received and accepted the resignation of CEO Julian Lob-Levyt. As a result of this resignation, a number of prompt decisions need to be made by the Board, including the appointment of an interim CEO and the approval of a process to manage recruitment of a new permanent CEO. The Board is also asked to consider Mary Robinson’s offer to extend her terms as Chair and Unaffiliated Board Member until 31 March 2011.

Agenda.

Final minutes from the 13 August 2010 Teleconference.

The Board approved a strategy for 2011-2015. In addition, it approved pilot prioritisation mechanism, programme funding system, resource envelope for cash-based programmes, and Board gender guidelines.

Final minutes from the 16-17 June 2010 Board meeting.

This document is a consolidated report on the 2009 work plan, within the GAVI Alliance 2007-10 Strategy. It is based on the reporting provided by WHO, UNICEF, World Bank and the GAVI Secretariat. No requests are being made of the Board.

The Executive Committee approved India for DTP-HepB-Hib pentavalent vaccine in July 2009 with an overall commitment for US$ 165 million through 2011. Until recently the Indian Government has indicated that it is reconsidering plans to introduce pentavalent vaccine and proposes that the vaccine should be introduced in late 2010 in five states instead of the original ten.

The PPC is recommending a new method for allocating the maximum grant an eligible country could receive through the Health Systems Strengthening (HSS) programme. Compatible with the four principles the Prioritisation Task Team identified (supporting nationally-defined priorities, objectivity, transparency and feasibility), the new formula better allocates funds toward the countries with the greatest need.

Noting that whilst keeping a vaccine focus, an integrated vision of vaccines and system building has become core to the GAVI mission and a powerful tool for fundraising, the right balance needs to be struck. The issue is in part highlighted by the prioritisation discussions and by the decision before the Board on the use of the remaining notional Health Systems Strengthening (HSS) funds. Two decisions are presented for the Board’s consideration.

The PPC would like to request the Board to approve certain co-financing objectives and principles. Pending board approval of the proposed objective and principles, a second stage of work will define policy options for country groupings; co-financing levels and trajectories over time; the default mechanism; and risk management.

Because of the important role that civil society plays in immunisation and the GAVI Alliance, the CSO constituency believes that there should be two civil society seats on the GAVI Alliance Board: one representing Northern (industrialised country) CSOs and the other representing Southern (developing country) CSOs.

This document concerns GAVI's approach to risk management as seen from the perspective of the recently established Internal Audit function and covers GAVI's current approach to risk management; recent important improvements and suggestions for further improvement.

CEO report to the Board.

Because of differences in the governance and audit calendars, the Board does not meet at a convenient time to consider and approve the annual financial statements. Further, the Statutes forbid delegation to the Executive Committee. The result would be special phone meetings each year to make this approval.The Board is asked to approve a By-Law that would allow it to take this decision by no-objection voting.

The Director of Internal Audit proposed to the Audit and Finance Committee that it review several modest revisions to the Document Retention Policy.

A final draft of the GAVI Alliance Strategy 2011-2015 has been prepared for Board approval. In addition, a draft concept note outlining the process for developing a comprehensive business plan for the five-year strategic period has been prepared for information.

The Board will be requested to approve the PPC’s recommendations with regard to prioritisation, co-financing, health systems strengthening programme allocations, and the advance market commitment.

The Governance Committee of the GAVI Alliance Board has held two meetings since the November 2009 board meeting. This paper provides a brief summary of issues discussed.

The offices of Treasurer and Secretary are currently vacant. The Board is requested to appoint Barry Greene as Treasurer effective immediately and Debbie Adams as Secretary effective 1 August 2010.